WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2025

Oct 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2025-09-30

Reporting Person: HAUGEN JANET BRUTSCHEA (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-30	Phantom Stock Unit	$	A	48	Acquired		Common Stock (48)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1319.348	Direct

Footnotes

F1: Reflects 1,071 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

F2: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.